Search Results

Biomed Israel , the premier international Life Science and HealthTech conference in Israel , will take place on May 21-23, 2024 , at the David InterContinental Hotel in Tel Aviv, Israel.

Axogen, Inc. announces the launch of its newest product, Avive+ Soft Tissue Matrix™. Avive+™ is intended for use as a soft tissue barrier and is a resorbable, multi-layer amniotic membrane allograft that provides temporary protection and tissue separation during the critical phase of peripheral nerve healing.

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announces the first surgical implantations of its newest product, Avive+ Soft Tissue Matrix™.

SOPHiA DDMTM HRD Solution will help empower clinical researchers to advance cancer research SOPHiA GENETICS, a cloud-native software company in the healthcare space and a leader in data-driven medicine, announced that Tel Aviv Sourasky Medical Center, the largest acute care facility in Israel, has chosen to use SOPHiA DDM™ to enhance its genetic testing capabilities.

Protalix BioTherapeutics, Inc. announced that the Company’s management and Board of Directors have decided that it is in the best interest of the Company to voluntarily delist its common stock from the Tel Aviv Stock Exchange.

Inspira™ Technologies announced today that the company will present at the annual iECOs Conference in Tel Aviv, Israel on November 10th, 2022.

IceCure Medical Ltd. (Nasdaq: ICCM) (“IceCure”, “IceCure Medical” or the “Company”) today announced that data from an interim analysis of its ICESECRET kidney cancer trial were presented at the 3rd Annual Israeli Conference on Interventional Radiology in Tel Aviv, Israel on June 10, 2024.

BiomX Inc., a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, announced that it is voluntarily delisting its shares of common stock from trading on the Tel Aviv Stock Exchange.

Veru Inc. announced that Mitchell Steiner, M.D., Chairman, President, and Chief Executive Officer, will be a Keynote Speaker at Biomed Israel 2024: The 22nd National Life Science & Technology Week, taking place May 21-23, 2024, in Tel Aviv, Israel.

Aviv Clinics, one of the world’s most advanced brain clinics, shares the results of a new case report showing a unique hyperbaric oxygen therapy (HBOT) protocol was effective for improving hand motor function in a chronic post-stroke patient.